Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Pharmacology

  • 1
    News

    What 2019’s top five CAD trials tell us

    January 29, 2020

    SNOWMASS, COLO. – Triple therapy as a triple threat – a three-pronged threat to patient safety, Dr. Malcolm R. Bell says.

  • 1
    News

    Cardiac biomarkers refine antihypertensive drug initiation decisions

    January 22, 2020

    PHILADELPHIA – Analysis showcases a better way to select patients for intensive BP lowering.

  • 1
    News

    ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding

    December 16, 2019

    LOS ANGELES – Use of novel oral anticoagulants may be preferred over vitamin K antagonists in patients with diabetes and AFib.

  • 1
    News

    New heart failure trial data presage guideline revisions

    December 9, 2019

    PHILADELPHIA – Recent trial findings for sacubitril/valsartan and dapagliflozin in heart failure patients provide a blueprint for guideline changes.

  • 1
    News

    Aspirin plus a DOAC may do more harm than good in some

    December 8, 2019

    Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication increased bleeding risks in a large cohort.

  • 1
    News

    DAPA-HF: Dapagliflozin benefits regardless of age, HF severity

    November 25, 2019

    PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.

  • News

    What’s new in hepatitis C: Four themes that dominated at the Liver Meeting

    November 22, 2019

    BOSTON – AASLD highlights included treatment of persons who inject drugs, new directions in pangenotypic therapy, benefits of sustained virologic response, preemptive therapy in donor-positive organ transplant.

  • 1
    News

    CDC releases update of 2013 Antibiotic Resistance Threats Report

    November 14, 2019

    The report includes the hopeful news that there were 42 new antibiotics in development as of June 2019.

  • News

    Dapagliflozin approved for reducing HF hospitalization in diabetes

    October 21, 2019

    It is the first SGLT2 inhibitor approved in the United States for this indication in adults with type 2 disease.

  • 1
    News

    Certain diabetes drugs may thwart dementia

    October 21, 2019

    COPENHAGEN – Intriguing findings from a Danish national registry study.

Previous1 … 5 6 7 8 9 … 13Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences